What's new

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 26, Status: Authorised

Apr 22, 2025 - 15:43
 0
Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, D...

Next Article

Toyo begins production at 2GW solar cell plant in Ethiopia

Related Posts

Orphan designation: xevinapant Treatment of ovarian cancer, 11/11/2015 Withdrawn

Orphan designation: xevinapant Treatment of ovarian can...

Feb 20, 2025  0

Medicine shortage communications (MSC)

Medicine shortage communications (MSC)

Apr 7, 2025  0

EMEA-003423-PIP02-23

EMEA-003423-PIP02-23

Apr 14, 2025  0